Replies to post #218736 on Biotech Values

[DewDiligence]

In light of DaveAu’s post (#msg-140350928), my estimation is that ENTA Mavyret royalties will fall into the lowest tier during 1Q18 and 2Q18, may break into a higher tier during 3Q18, and are very likely to attain a higher tier during 4Q18.